The Burden of Menstrual Migraine: Advances in diagnosis, treatment, and understanding of pathogenesis

The Burden of Menstrual Migraine: Advances in diagnosis, treatment, and understanding of pathogenesis

Menstrual migraine is a debilitating neurological condition linked to hormonal fluctuations during the menstrual cycle. It disproportionately affects women of reproductive age, imposing significant personal and societal burdens. Characterized by intense, prolonged headaches often resistant to stand...

Full description

Saved in:

Bibliographic Details
Main Authors:	Paulina Głogowska, Daria Furtak, Dawid Tulej, Alicja Dziedzic, Wiktor Grela, Jagoda Niewiadomska, Natalia Marko, Natalia Gniaź, Dominika Marciniuk, Aleksandra Górska
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2025-05-01
Series:	Journal of Education, Health and Sport
Subjects:	menstrual migraine acute treatment prevention triptans CGRP antibodies hormonal therapy
Online Access:	https://apcz.umk.pl/JEHS/article/view/60098
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Migraine in the triptan era: progresses achieved, lessons learned and future developments Migrânea na era dos triptanos: progressos alcançados, lições aprendidas e desenvolvimentos futuros
by: Marcelo E. Bigal, et al.
Published: (2009-06-01)

Exploring the Role of Tranexamic Acid in Dermatology: A literature Review
by: Aleksandra Górska, et al.
Published: (2025-01-01)

Glucagon-like peptide-1 receptor agonists as a Therapeutic Option for Antipsychotic-Induced Obesity: A Review of Current Evidence
by: Natalia Gniaź, et al.
Published: (2024-12-01)

The Efficacy of Dog Assisted Therapy in depression and anxiety – a review
by: Dominika Marciniuk, et al.
Published: (2025-02-01)

Postural Orthostatic Tachycardia Syndrome (POTS) – A Review of Pathophysiological Mechanisms, Diagnosis and Therapy
by: Alicja Dziedzic, et al.
Published: (2024-11-01)

Cardiac Syndrome X: Advances in Treatment for Chest Pain without Artery Stenosis
by: Dawid Tulej, et al.
Published: (2024-12-01)

Refeeding syndrome as a serious complication of a treatment of patients with anorexia nervosa - a literature review
by: Natalia, et al.
Published: (2025-04-01)

Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study)
by: Luigi Francesco Iannone, et al.
Published: (2025-01-01)

Differences in pharmacological migraine treatment across different levels of clinical headache care – a cross-sectional study
by: Mira Pauline Fitzek, et al.
Published: (2025-04-01)

The use of triptans as an effective form of migraine treatment – review
by: Agata Borkowska, et al.
Published: (2025-01-01)

Evaluation of the effectiveness of greater occipital nerve blockade in menstrual migraine
by: Guldeniz Cetin, et al.
Published: (2025-02-01)

Mechanistic approach and therapeutic strategies in menstrual and non-menstrual migraine
by: Tanya Mani, et al.
Published: (2025-12-01)

Developing The Menstrual Migraine Symptoms Scale
by: Ayhan Parmaksız, et al.
Published: (2025-07-01)

Migraine headaches in a nutshell
by: Natalie Schellack, et al.
Published: (2017-12-01)

Efficacy and safety of Russian tableted rizatriptan 10 mg in the treatment of migraine attacks in clinical practice
by: E. G. Filatova, et al.
Published: (2024-08-01)

NSAIDs and Triptans – a (not) New Treatment Option for Migraine
by: B. Kakta, et al.
Published: (2023-12-01)

Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis
by: Chen J, et al.
Published: (2025-06-01)

Interictal burden in migraine patients at the outset of CGRP monoclonal antibody prevention
by: Christian Lampl, et al.
Published: (2024-12-01)

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study
by: M. Lanteri-Minet, et al.
Published: (2025-07-01)

Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not sorted into axons
by: Sofia Lyng Wæver, et al.
Published: (2025-01-01)

Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies
by: Gabriel Gárate, et al.
Published: (2025-05-01)

Effect of combined oral contraceptives on menstrual migraine frequency and severity: a narrative review
by: Yethindra Vityala, et al.
Published: (2024-09-01)

Chronic Migraine: Diagnosis, Characteristics, Lifestyle Modification, Trigger Reduction and Treatment
by: Roshan Kumar Jha, et al.
Published: (2024-12-01)

Efficacy of fremanezumab in patients with chronic migraine and concomitant depression
by: A.Y. Timokhovich, et al.
Published: (2024-10-01)

“The efficacy and safety of Atogepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials”
by: Ayesha Shaukat, et al.
Published: (2025-08-01)

Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug
by: Krymchantowski Abouch V., et al.
Published: (2001-01-01)

New specific migraine prevention: monoclonal antibodies against calcitonin gene-related peptide and its receptor
by: K. Ryliškienė, et al.
Published: (2019-12-01)

Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine
by: Fahimeh Martami, et al.
Published: (2025-05-01)

Efficacy of anti-calcitonin gene-related peptide monoclonal antibodies in hemiplegic migraine: a case report and review of literature
by: Máté Héja, et al.
Published: (2025-04-01)

Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
by: Adarsh Raja, et al.
Published: (2024-09-01)

Corrigendum: Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults
by: Adarsh Raja, et al.
Published: (2025-04-01)

Effectiveness and Safety of CGRP-Targeted Therapies Combined with Lifestyle Modifications for Chronic Migraine in Korean Pediatric Patients: A Retrospective Study
by: Ji-Hoon Na, et al.
Published: (2025-05-01)

Seasonal Variations in Triptan Prescription in Japan: A Nationwide Time‐Series Analysis
by: Muneto Tatsumoto, et al.
Published: (2024-12-01)

Comprehensive safety analysis of adverse events associated with eptinezumab in migraine treatment
by: Junchen Chen, et al.
Published: (2025-07-01)

Disrupting Migraine Dynamics: A Narrative Review of the Consequences of Modern Anti-CGRP Monoclonal Antibody Therapies
by: Dawn C. Buse, et al.
Published: (2025-05-01)

Gepants in Primary Care: A Targeted Approach to Acute and Preventive Treatment of Migraine
by: Maureen A. Moriarty, et al.
Published: (2025-06-01)

A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland
by: Caroline S. Casey, et al.
Published: (2025-04-01)

Sex hormone profiles in men with migraine: a cross-sectional, matched cohort study
by: Paul Triller, et al.
Published: (2025-08-01)

Cerebral Artery Vasoconstriction After Galcanezumab Loading Dose for Migraine Prevention: A Case Report
by: Thanin Asawavichienjinda, et al.
Published: (2024-10-01)

Headaches during pregnancy in women with a prior history of menstrual headaches Cefaléia durante a gestação em mulheres com história de cefaléia menstrual
by: Eliana Melhado, et al.
Published: (2005-12-01)